Neuronetics (STIM) Capital Expenditures (2017 - 2026)

Neuronetics (STIM) has 10 years of Capital Expenditures data on file, last reported at $197000.0 in Q1 2026.

• On a quarterly basis, Capital Expenditures rose 358.14% year-over-year to $197000.0 in Q1 2026; TTM through Mar 2026 was $955000.0, a 720.13% increase from a year earlier, with the FY2025 full-year figure at $801000.0, up 6061.54% from the prior year.
• Capital Expenditures for Q1 2026 stood at $197000.0, down from $216000.0 in the prior quarter.
• Over the last five years, Capital Expenditures for STIM reached as high as $1.1 million in Q1 2022 and fell as low as -$603000.0 in Q3 2023.
• Historically, Capital Expenditures has averaged $265823.5 across 5 years, with a median of $210000.0 in 2024.
• Across the five-year window, Capital Expenditures slumped 183.06% in 2023 and surged 559.52% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $503000.0 in 2022, then sank by 119.09% to -$96000.0 in 2023, then soared by 43.75% to -$54000.0 in 2024, then surged by 500.0% to $216000.0 in 2025, then slipped by 8.8% to $197000.0 in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $197000.0 in Q1 2026, $216000.0 in Q4 2025, and $579000.0 in Q3 2025.